Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 2/20 | 0.32 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24839550 | 1.00 | CDC14B (0.32) | CDC14BCDC14APLA2G2APLA2G4AALOX5 | |
| SCHEMBL25578831 | 1.00 | CDC14B (0.32) | CDC14BCDC14APLA2G2APLA2G4AALOX5 | |
| SCHEMBL25578775 | 0.96 | PLA2G2A (0.37) | CDC14BCDC14APLA2G2APLA2G4AALOX5 | |
| SCHEMBL25577374 | 0.96 | BACE1 (0.32) | CDC14BCDC14AALOX5NTRK1PLK3 | |
| SCHEMBL24840162 | 0.95 | PLA2G2A (0.36) | CDC14BCDC14APLA2G2APLA2G4AALOX5 | |
| SCHEMBL27017871 | 0.95 | CDC14B (0.32) | CDC14BCDC14APLA2G2APLA2G4AALOX5 | |
| SCHEMBL25608147 | 0.95 | PLA2G2A (0.33) | CDC14BCDC14APLA2G2APLA2G4AALOX5 | |
| SCHEMBL25578914 | 0.95 | CDC14B (0.33) | CDC14BCDC14ANTRK1PLK3CA1 | |
| SCHEMBL25578689 | 0.94 | CA12 (0.34) | CA1CA2L3MBTL1MAPT | |
| SCHEMBL25580678 | 0.94 | CDC14B (0.32) | CDC14BCDC14APLA2G2APLA2G4AALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230165139-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| WO-2023273998-A1 | COMPOUND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE | 北京鼎材科技有限公司 | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165139-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | OR10J3, PIEZO1, OR51E2 | CDC14B 3417/4885CDC14A 3110/4885PLA2G2A 3822/4885 |
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | ESR1, L1CAM, ESR2 | CDC14B 4631/4885CDC14A 4607/4885PLA2G2A 2335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.